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INTRODUCTION 
Among all the drug administration routes, 
the oral one is the most preferred by the 
patients being less invasive, faster and 
easier. 
Oral drug delivery systems designed to 
target the intestine are produced by powder 
technology and capsule formulations. 
Those systems including micro- and nano-
particulate systems (i.e. vesicles, polymer 
nanoparticles, dendrimers etc.) suffer the 
non-unidirectional release of the drug to 
the epithelium of the intestine, which 
entails an inevitable loss in the lumen and, 
therefore, the reduction of the drug 
delivered to the intestinal epithelium. A 
new promising approach focuses on 
reservoir based microdevices serving as 
carriers for poorly soluble drugs, hereby 
called microcontainers (1).  
Microcontainers have a cylindrical 
geometry and provide a unidirectional 
release due to their design meanwhile 
protecting the drug formulation from the 
low gastric pH and the enzymatic 
degradation. Here, we present the 
preparation of microcontainers with enteric 
coating (2) efficiently loaded with drug 
and able to target the intestine as a multi-
particulate system.  
 
MATERIALS AND METHODS 
25 x 25 array of microcontainers were 
fabricated (Figure 1a) on a Silicon chip as 
previously described (1) implementing a 
sacrificial layer in polyacrylic acid (PAA) 
(Mw = 100 kDa, Sigma-Aldrich) (3). This 
allows the release of the microcontainers 
from the Silicon support upon PAA 
solubilisation in deionized water (Figure 
1d). 
Microcontainers on the PAA layer were 
filled with polyvinylpyrrolidone K10 
powder (Mw = 10 kDa, Sigma-Aldrich) 
removing the excess with compressed air. 
Polymer filled microcontainers (Figure 1b) 
were then impregnated with ketoprofen 
(Sigma-Aldrich) by means of supercritical 
impregnation technology (100 Bar, 40 °C 
for 1 hour), as previously shown (4). 
Drug loaded microcontainers were coated 
through a nickel shadow mask (5) using a 
solution of Eudragit L100
®
 2% w/V 
(Evonik Mw = 125 kDa) with 
Dibutylsebacate 5% w/w (Sigma-Aldrich) 
as plasticizer in 2-propanol. The Eudragit 
film was deposited on top of the 
microcontainers (Figure 1c) via spray 
coating (Sonotek, U.S.). 
Microcontainers were released from the 
supporting layer by dissolution of the 
underlying PAA layer in DI water at pH = 
3.25 (Figure 1d). Containers were then 
poured in dialysis tubes and inserted in 
Biorelevant gastric medium (pH = 1.65) – 
FaSSGF for 2 hours at 37 °C. The same 
tubes were subsequently placed in 
Biorelevant intestinal medium (pH = 6.5) – 
FaSSIF for 6 hours at 37 °C. 
Samples were prelevated during 
ketoprofen release (Figure 1e) and 
analysed by means of UV-Spec at = 259 
nm (NanoDrop, Thermo Scientific). 
 
 
 
Fig. 1: Scheme of the process. 
RESULTS AND DISCUSSION 
Microcontainers with PAA layer were 
successfully loaded by supercritical 
impregnating PVP K10 with ketoprofen 
using pressured CO2 as a solvent (Figure 
2a). Drug loaded microcontainers were 
coated with Eudragit L100
®
 to avoid the 
drug being released in the gastric medium 
(Figure 2b) since the polymer is not 
dissolved in the gastric fluid (pH = 1.65, 
fasted state) while it is quickly solubilized 
upon reaching the intestinal, less acidic, 
environment. 
 
 
 
 
Fig. 2: SEM picture of drug loaded microcontainer: (a) 
before and (b) after the Eudragit L100
®
 coating. 
 
Due to the underlying PAA layer we 
successfully detached the microcontainers 
from the silicon support through 
immersion in deionized water (pH = 3.25) 
for about 2 minutes. The PAA layer is 
dissolved releasing the containers.  
Ketoprofen is released differently between 
coated and uncoated microcontainers as 
shown in Figure 3. 
After 2 hours at pH 1.65 approximately 
70% of ketoprofen is released from the 
uncoated microcontainers while less than 
20% is released from the coated 
microcontainers. 
At pH 6.5 coated and uncoated 
microcontainers released the drug with 
very similar profiles. Coated 
microcontainers showed a burst release as 
soon as the pH was changed, proving the 
fast dissolution of both the Eudragit L100
®
 
and the impregnated PVP containing the 
drug.  
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Fig. 3: Ketoprofen dissolution profiles represented as 
cumulative release (%); the evident difference between the 
black and the red profiles defines the efficacy of the enteric 
coating preventing the drug to be released in the acidic pH 
(before 120 min). 
 
CONCLUSIONS 
Microcontainers fabricated on a sacrificial 
PAA layer were successfully used as drug 
carriers for the targeted release of 
ketoprofen in the intestine.  
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